Therapeutic and diagnostic developers gain flexibility, speed, and scalability to advance custom formulations from preclinical research to manufacturing for clinical trials, with a reviewed quote returned in under three business days HOLLISTER, Calif. — Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, […]
Rainer Blair to retire WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or “the Company”) announced that the Company’s Board of Directors has appointed Julie Sawyer Montgomery as President and Chief Executive Officer and a member of the Board of Directors, effective October 1, 2026. On that date, Rainer Blair will retire and serve as a […]
Collaboration, coordinated through NCSTAR at QIMR Berghofer, gives Queensland researchers a pathway to trial and validate MGI’s integrated DCSP framework — spanning DNA genomics, cell omics, spatial omics and proteomics — locally, fast-tracking their translation into real-world research and future clinical applications. Brisbane, Australia — MGI Australia, the local Australia and New Zealand team of MGI Tech Co., Ltd. (MGI), […]
Stockholm-based service provider adds Evercode to its single cell sequencing offerings SEATTLE — Parse Biosciences, the leading provider of scalable and accessible single cell sequencing, and a QIAGEN company, today announced that Xpress Genomics has joined its Certified Service Provider (CSP) program, becoming the first in the Nordic region. The Stockholm-based company will offer Parse’s Evercode single cell […]
Agreement marks the start of Eppendorf’s planned manufacturing facility in Penang Eppendorf will invest EUR 40 million in the site, with production expected to start in 2028 New facility will produce selected products of the Centrifuges & Instruments portfolio for global laboratory markets Penang, Malaysia – Eppendorf has signed an agreement for a new production […]
Collaboration aims to identify biomarkers predictive of treatment response across multiple cancer types using 10x’s single cell and spatial platforms PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced a research collaboration with Lausanne University Hospital (CHUV), one of Switzerland’s leading academic […]
CAMARILLO, Calif. — PBS Biotech, a leader in advanced cell therapy manufacturing technologies, today announced its membership in Organoid COMMONS. As a member of this industry-first consortium, PBS Biotech will collaborate with biopharma pioneers to establish the biomanufacturing standards and scalable frameworks required to transition organoid technologies from early-stage drug discovery to commercial-scale application. Organoid […]
Sale of Mass Cytometry Business to Multiplex Bio Ensures Full Continuity of CyTOF and Hyperion Product Lines, Customer Relationships, Dedicated Team and Continued Investment in Next Generation Multiplex Platforms Receives Approximately $30 Million in Negotiated Buyout Related to Contingent Consideration Obligations From Illumina’s Acquisition of SomaLogic Business BOSTON, Mass. — Standard BioTools Inc. (NASDAQ: LAB) (“Standard BioTools” or the […]
Financing includes a $17 million senior credit facility from BOK Financial and $8 million in equity from existing investors and global single-family offices. SAN FRANCISCO — Excedr, Inc. (“Excedr” or the “Company”), a leading provider of full-service laboratory equipment leasing solutions for the life sciences and healthcare industries, today announced the closing of $25 million […]
WALTHAM, Mass. — Nova Biomedical today announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. This expands Nova Biomedical’s capabilities in cell line development and strengthens its ability to support biopharmaceutical workflows from early development through manufacturing. NanoCellect® WOLF G2® cell sorting platform introduces gentle, microfluidic-based cell selection and isolation, complementing […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
